AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis

Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health

(2018) Clement K. Ho et al.   ACTA ONCOLOGICA

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity

(2018) Huijuan Zhu et al.   Frontiers in Endocrinology

Current status of theranostics in prostate cancer

(2017) Irene Virgolini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways

(2016) Ming-Yi Xu et al.   CANCER LETTERS

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer

(2016) Jingwen Zhao et al.   Oncotarget

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

(2015) Christoph Burdelski et al.   INTERNATIONAL JOURNAL OF CANCER

JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles

(2015) Anthony Mathelier et al.   NUCLEIC ACIDS RESEARCH

miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4

(2015) JIA-JUN CAI et al.   ONCOLOGY REPORTS

Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion

(2015) Xiaokun Gang et al.   PROSTATE

CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression

(2014) K.-i. Takayama et al.   CANCER RESEARCH

The Role of Snail in EMT and Tumorigenesis

(2014) Yifan Wang et al.   CURRENT CANCER DRUG TARGETS

Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast

(2014) Seow Foong Loh et al.   JOURNAL OF CLINICAL PATHOLOGY

Prostate cancer in young men: an important clinical entity

(2014) Claudia A. Salinas et al.   Nature Reviews Urology

Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer

(2013) Nima Sharifi   MOLECULAR ENDOCRINOLOGY

Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms

(2013) LAETITIA DELORT et al.   ONCOLOGY REPORTS

Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer

(2013) Wenjuan Mo et al.   PLoS One

The Kinetics of G2 and M Transitions Regulated by B Cyclins

(2013) Yehong Huang et al.   PLoS One

FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants

(2013) Laura R. Bohrer et al.   PROSTATE

Androgen action and metabolism in prostate cancer

(2012) Sean M. Green et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Blockade of testicular and adrenal androgens in prostate cancer treatment

(2011) Fernand Labrie   Nature Reviews Urology

Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)

(2010) Michael E. Jung et al.   JOURNAL OF MEDICINAL CHEMISTRY

Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities

(2010) Sven Heinz et al.   MOLECULAR CELL

Activation of Rac1 Is Closely Related to Androgen-Independent Cell Proliferation of Prostate Cancer Cells Bothin Vitroandin Vivo

(2010) Takashi Kobayashi et al.   MOLECULAR ENDOCRINOLOGY

AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling

(2010) B Kong et al.   ONCOGENE

C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results

(2010) Renee C. Prins et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion

(2009) X N Meng et al.   BRITISH JOURNAL OF CANCER

A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells

(2008) P. Liu et al.   CANCER RESEARCH

Targeting the androgen receptor pathway in prostate cancer

(2008) Yu Chen et al.   CURRENT OPINION IN PHARMACOLOGY

Zinc  2-Glycoprotein: A Multidisciplinary Protein

(2008) Md. I. Hassan et al.   MOLECULAR CANCER RESEARCH

ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer

(2007) David P Turner et al.   Expert Review of Anticancer Therapy